Confluent reticulated papillomatosis o se dermatosis ichthyosiform e le masani ai ae fa'apitoa e fa'aalia i le pogisa faifai pea, pa'u, pa'epa'e, ma masani ona maua i luga o le ogalaau tutotonu. O le fa'ama'i e mafai ona togafitia i le Minocycline.
Confluent and reticulated papillomatosis of Gougerot and Carteaud is an uncommon but distinctive acquired ichthyosiform dermatosis characterized by persistent dark, scaly, papules and plaques that tend to be localized predominantly on the central trunk.
☆ AI Dermatology — Free Service I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
Tulaga masani — E foliga mai o se mea lanu uliuli e leʻi iai ni fa'ailoga (feu, tiga) i le puimanava.
Confluent and reticulated papillomatosis (CRP), e ta'ua fo'i le ma'i Gougerot‑Carteaud, e mafua mai i le tuputupu a'e o le pa'u e le masani ai. E aliali mai o ni mea pogisa e le tiga, e mafai ona tuʻufaʻatasia i paʻu tetele; e masani ona aliali i luga o le fatafata ma le ua o talavou ma talavou matutua. O le filifiliga muamua mo le togafitiga o le minocycline. Confluent and reticulated papillomatosis (CRP), also known as Gougerot-Carteaud syndrome, is caused by disordered keratinization. It presents with asymptomatic hyperpigmented papules that can coalesce into plaques and are typically located on the upper trunk and neck of teens and young adults. First-line treatment is oral 'minocycline'.
O le CRP e masani ona aliali mai o ni mea pogisa ma paʻu e aunoa ma ni faʻailoga i luga o le paʻu, i le ua, lima, fatafata pito i luga, ma tua i luga. O nisi taimi, e mafai ona sosolo i luga i le mauulu ma i lalo i le vaega o le pubic. O vaila'au fa'ama'i e pei o le minocycline ua avea ma filifiliga sili mo togafitiga. CRP typically presents as asymptomatic hyperpigmented papules and plaques with peripheral reticulation over the nape, axillae, upper chest, and upper back, occasionally with extension superior to the forehead and inferior to the pubic region. Antibiotics, such as 'minocycline', at anti-inflammatory doses have emerged as a preferred therapeutic option.
○ Togafitia
Minocycline